Trial Profile
A Randomized, Double-blind, Placebo- and Positive-controlled, Parallel Study to Evaluate the Effect of SYR-472 on the QT/QTc Interval in Healthy Adult Male and Female Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Trelagliptin (Primary) ; Moxifloxacin
- Indications Bacterial infections; Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Takeda
- 18 Jul 2011 New trial record